Novo Nordisk stock news
On October 19, 2026, Novo Nordisk published a status update on its capital allocation activities under its DKK 15 billion share repurchase programme initiated on February 4, 2026. Between October 12 and October 16, 2026, the company repurchased 1,225,000 B shares. Under the active sub--programme initiated on May 6, 2026—which authorizes buybacks of up to DKK 11.2 billion through February 1, 2027—Novo Nordisk has acquired an aggregate of 24,315,000 B shares for DKK 7.08 billion. Across the full 2026 framework to date, cumulative repurchases have reached 39,074,179 B shares at an average transaction price of DKK 278.32 per share, totaling approximately DKK 10.88 billion. Novo Nordisk now holds 53,114,876 B shares as treasury stock, representing 1.2% of its total share capital.